Speaker illustration

Doctor Salva Reverentia Yurista

Massachusetts General Hospital - Harvard Medical School, Boston (United States of America)

Member of:

EAPCI
Heart Failure Association

Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with heart failure after myocardial infarction

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Pharmacotherapy

Session: Moderated Poster Session - Basic Science

Thumbnail

This platform is supported by

logo Novo Nordisk